Sentences and paragraphs of WAT's Risk Factors and MD&A, 10-K 2026-02-23 against 10-K 2025-02-25.
Each links to the text at sec.gov.
RemovedRisk Factors
Public health crises, epidemics or pandemics have had, and could in the future have, a negative impact on the Company’s business and operations.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedRisk Factors
Public health crises, epidemics or pandemics have had, and could in the future have, a negative impact on our business and operations, including Company sales and cash flow. Such public health crises, epidemics and pandemics have the potential to create significant volatility, uncertainty and worldwide economic disruption, resulting in an economic slowdown of potentially extended duration, as seen with the COVID-19 pandemic from 2020 to 2022. The Company’s global operations expose it to risks associated with such public health crises, epidemics and pandemics, which could have an adverse effect on its business, results of operations and financial condition. The degree to which such public health crisis, epidemics or pandemics ultimately affects the Company’s business, results of operations and financial condition is highly uncertain and cannot be predicted.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedRisk Factors
The demand for the Company’s products is dependent upon the size of the markets for its LC, LC-MS, light scattering, thermal analysis, rheometry and calorimetry products; the timing and level of capital spending and expenditures of the Company’s customers; changes in governmental regulations, particularly those affecting drug, food and drinking water testing; funding available to academic, governmental and research institutions;
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedRisk Factors
The Company’s software or hardware may contain coding or manufacturing errors that could impact their function, performance and security, and result in other negative consequences.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedRisk Factors
The loss of key members of management and the risks inherent in succession planning could adversely affect the Company’s results of operations or financial condition.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedRisk Factors
The operation of the Company requires managerial and operational expertise. None of the Company’s key management employees, with the exception of the Chief Executive Officer and Chief Financial Officer, have an employment contract with the Company and there can be no assurance that such individuals will remain with the Company. If, for any reason, other key personnel do not continue to be active in management, the Company’s results of operations or financial condition could be adversely affected. The Company’s success also depends on its ability to execute leadership succession plans. The inability to successfully transition key management roles could have a material adverse effect on the Company’s operating results.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedRisk Factors
The Company is subject to the rules of the SEC under the Dodd-Frank Wall Street Reform and Consumer Protection Act, which require disclosure as to whether certain materials (tantalum, tin, gold and tungsten), known as conflict minerals, which may be contained in the Company’s products, are mined from the Democratic Republic of the Congo and adjoining countries. In 2023, the Company was not able to determine with certainty the country of origin of some of the conflict minerals in its manufactured products. However, the Company does not have knowledge that any of its conflict minerals originated from the Democratic Republic of the Congo or adjoining countries. The Company is in the process of evaluating its 2024 supply chain, and the Company plans to file its 2024 Form SD with the SEC in May 2025. The results of this and future evaluations may impose additional costs and may introduce new risks related to the Company’s ability to verify the origin of any conflict minerals contained in its products.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedRisk Factors
The Company had $1.6 billion in debt and $325 million in cash, cash equivalents and investments as of December 31, 2024. As of December 31, 2024, the Company also had the ability to borrow an additional $1.6 billion from its existing, committed credit facility. All but a small portion of the Company’s debt was in the U.S. There is a substantial cash requirement in the United States to fund operations and capital expenditures, service debt interest obligations, finance potential United States acquisitions and continue authorized stock repurchase programs. As such, the Company’s financial condition and results of operations could be adversely impacted if the Company is unable to generate and maintain a sufficient level of cash flow to address these requirements through (1) cash from operations, (2) the Company’s ability to access its existing cash and revolving credit facility, (3) the ability to expand the Company’s borrowing capacity and (4) other sources of capital obtained at an acceptable cost.
Read it in 10-K 2025-02-25 at sec.gov ↗
Show the other 8
RemovedMD&A
The increase in 2023 is primarily driven by severance-related costs in connection with a reduction in workforce, which increased expenses by 4%; the Wyatt acquisition due diligence and integration costs, which increased expenses by 2%; and the Wyatt acquisition-related retention expense, which increased expenses by 3%. These increases were partially offset by lower incentive compensation costs. The increase in selling and administrative expenses in 2023 as compared to 2022 can be attributed to higher salary merit and variable incentive compensation costs due to an increase in the number of employees. The effect of foreign currency translation had minimal impact on selling and administrative expenses in 2024 and 2023.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedMD&A
In 2022, the Company completed an asset acquisition in which the CDMS technology assets of Megadalton were acquired for approximately $10 million in total purchase price, of which $5 million was paid at closing and the remaining $4 million will be paid in the future at various dates through 2029.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedMD&A
In 2022, the Company sold an equity investment for $10 million in cash and recorded a gain on the sale of approximately $7 million in other income, net on the statement of operations. The Company also incurred $6 million in losses on an equity investment in 2022 within other income, net on the statement of operations.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedMD&A
Year Ended December 31, 2024 2023 2022 Net income $ 637,834 $ 642,234 $ 707,755 Depreciation and amortization 191,825 165,905 130,423 Stock-based compensation 44,709 36,868 42,564 Deferred income taxes (877) (1,197) (31,988) Acquired in-process research and development and other non-cash items — — 10,003 Change in accounts receivable (66,240) 49,179 (137,874) Change in inventories 20,943 (45,443) (101,902) Change in accounts payable and other current liabilities 61,585 (79,524) 60,984 Change in deferred revenue and customer advances 6,165 10,433 12,862 Other changes (133,821) (175,646) (81,166) Net cash provided by operating activities 762,123 602,809 611,661 Net cash used in investing activities (144,023) (1,442,265) (107,967) Net cash (used in) provided by financing activities (696,675) 754,951 (509,633) Effect of exchange rate changes on cash and cash equivalents 7,920 (948) (14,766) Decrease in cash and cash equivalents $ (70,655) $ (85,453) $ (20,705)
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedMD&A
The decrease in inventory can primarily be attributed to better inventory management and higher sales volume in the second half of 2024.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedMD&A
During 2024, 2023 and 2022, the Company purchased $4 million, $2 million and $11 million of investments, respectively, while $4 million, $2 million and $78 million of investments matured, respectively, and were used for financing activities described below.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedMD&A
In 2022, the Company paid $5 million for the CDMS technology and intellectual property right asset from Megadalton, and the Company is required to make an additional $4 million of guaranteed payments at various dates in the future through 2029. The total purchase price of approximately $10 million was accounted for as Acquired In-Process Research and Development and expensed as part of costs and operating expenses in the statement of operations in 2024.
Read it in 10-K 2025-02-25 at sec.gov ↗
RemovedMD&A
In our prior year acquisition of Wyatt in fiscal 2023, customer relationship intangible assets have been the most significant identifiable assets acquired. The customer relationships were valued using the multi-period excess earnings method under the income approach. Our cash flow projections for the customer relationships acquired included significant judgments and assumptions related to customer attrition rate, discount rate, and forecasted revenues. The value of the client relationships acquired was $331 million in fiscal year 2023, the majority of which relates to U.S. customer relationships.
Read it in 10-K 2025-02-25 at sec.gov ↗